BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 14133380)

  • 1. [TERSTOGENIC SUBSTANCES?].
    WEICKER H
    Med Klin; 1963 Dec; 58():2032-7. PubMed ID: 14133380
    [No Abstract]   [Full Text] [Related]  

  • 2. [TERATOGENIC SUBSTANCES?].
    VIVELL O
    Med Klin; 1964 Jan; 59():187. PubMed ID: 14127052
    [No Abstract]   [Full Text] [Related]  

  • 3. [DRUG USE DURING PREGNANCY AFTER DISCOVERY OF THALIDOMIDE EMBRYOPATHY].
    MAUSS HJ
    Dtsch Med Wochenschr; 1964 Feb; 89():380-3. PubMed ID: 14117097
    [No Abstract]   [Full Text] [Related]  

  • 4. THE TERATOGENIC ACTION OF DRUGS.
    MCBRIDE WG
    Med J Aust; 1963 Oct; 2():689-92. PubMed ID: 14069005
    [No Abstract]   [Full Text] [Related]  

  • 5. DRUG EMBRYOPATHY: THE THALIDOMIDE STORY.
    KELSEY FO
    Md State Med J; 1963 Dec; 12():594-7. PubMed ID: 14088464
    [No Abstract]   [Full Text] [Related]  

  • 6. [INVESTIGATION ON THE POSSIBLE RELATION OF FETAL INJURIES AND DRUGS. IV. RETROSPECTIVE STUDY ON DRUG CONSUMPTION AMONG MOTHERS WITH MALFORMED CHILDREN].
    WINBERG J
    Sven Lakartidn; 1964 Mar; 61():890-902. PubMed ID: 14142280
    [No Abstract]   [Full Text] [Related]  

  • 7. [ANATOMICAL FINDINGS OF THE SO-CALLED "THALIDOMIDE BABIES" WITH SPECIAL REFERENCE TO LIMBS].
    YAMANE H; KATO T; HOSODA Y
    Nihon Seikeigeka Gakkai Zasshi; 1965 Jan; 38():973-82. PubMed ID: 14299691
    [No Abstract]   [Full Text] [Related]  

  • 8. [EFFECT OF THALIDOMIDE ON THE PATHOGENESIS OF ABNORMALITIES IN NEWBORN INFANTS].
    SOYKOVA PACHNEROVA E
    Lek Veda Zahr; 1963 Aug; 8():162-6. PubMed ID: 14052093
    [No Abstract]   [Full Text] [Related]  

  • 9. OCULAR DEFECTS IN THALIDOMIDE BABIES.
    CULLEN JF
    Br J Ophthalmol; 1964 Mar; 48(3):151-3. PubMed ID: 14193669
    [No Abstract]   [Full Text] [Related]  

  • 10. [MECLIZINE AND FETAL MALFORMATIONS].
    MEYBERG J
    Med Welt; 1963 Nov; 47():2414-7. PubMed ID: 14113227
    [No Abstract]   [Full Text] [Related]  

  • 11. MATERNAL DRUG THERAPY AND CONGENITAL CATARACTS.
    HARLEY JD; FARRAR JF
    Med J Aust; 1964 Feb; 1():212-3. PubMed ID: 14126361
    [No Abstract]   [Full Text] [Related]  

  • 12. [MECLIZINE, THALIDOMIDE AND PREGNANCY].
    FEDERICI F
    Clin Eur; 1963; 102():50-5. PubMed ID: 14109124
    [No Abstract]   [Full Text] [Related]  

  • 13. METABOLISM OF MECLIZINE IN THE RAT.
    NARROD SA; WILK AL; KING CT
    J Pharmacol Exp Ther; 1965 Mar; 147():380-4. PubMed ID: 14269614
    [No Abstract]   [Full Text] [Related]  

  • 14. CANADIAN THALIDOMIDE EXPERIENCE.
    WEBB JF
    Can Med Assoc J; 1963 Nov; 89(19):987-92. PubMed ID: 14076167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EFFECTS OF PARENTAL THALIDOMIDE TREATMENT ON GESTATION AND FETAL DEVELOPMENT.
    STAPLES RE; HOLTKAMP DE
    Exp Mol Pathol Suppl; 1963 Dec; 2():81-106. PubMed ID: 14089666
    [No Abstract]   [Full Text] [Related]  

  • 16. EFFECTS OF THALIDOMIDE IN THE RAT FOETUS.
    OBBINK HJ; DALDERUP LM
    Experientia; 1963 Dec; 19():645-6. PubMed ID: 14099869
    [No Abstract]   [Full Text] [Related]  

  • 17. ORAL ANOMALIES INDUCED IN THE RAT BY MECLIZINE HYDROCHLORIDE.
    KENDRICK FJ; KING CT
    Oral Surg Oral Med Oral Pathol; 1964 Nov; 18():690-6. PubMed ID: 14199585
    [No Abstract]   [Full Text] [Related]  

  • 18. DRUG TESTING IN ANIMALS FOR TERATOGENIC EFFECTS. THALIDOMIDE IN THE PREGNANT RAT.
    BRENT RL
    J Pediatr; 1964 May; 64():762-70. PubMed ID: 14149012
    [No Abstract]   [Full Text] [Related]  

  • 19. MECLOZINE AND CONGENITAL MALFORMATIONS.
    PETTERSSON F
    Lancet; 1964 May; 1(7344):1221-2. PubMed ID: 14132672
    [No Abstract]   [Full Text] [Related]  

  • 20. AUTORADIOGRAPHIC INVESTIGATIONS OF 14-C-LABELLED THALIDOMIDE AND GLUTETHIMIDE IN PREGNANT MICE.
    KORANSKY W; ULLBERG S
    Proc Soc Exp Biol Med; 1964 Jun; 116():512-6. PubMed ID: 14193389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.